Skip to Main Content

Paper Details

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome.
Oncogene
135
2004
Author NameAffiliation
Christopher S FosterUniversity of Liverpool
  • 1 - 1

Datasets

Release 1.2